Market Research Report
PharmaSphere: Emerging Biotechnologies - Antisense RNAi Therapeutics Market Analysis
|Published by||GlobalData||Product code||340300|
|Published||Content info||124 Pages
|PharmaSphere: Emerging Biotechnologies - Antisense RNAi Therapeutics Market Analysis|
|Published: September 1, 2015||Content info: 124 Pages||
This publication has been discontinued on January 18, 2018.
GlobalData's "PharmaSphere: Emerging Biotechnologies - Antisense RNAi Therapeutics Market Analysis" report is an essential source of information and analysis on the RNA interference (RNAi) therapy field. Using detailed company data, deal analysis, corporate strategy, and market trends, GlobalData provides an in-depth analysis of the current and future growth drivers of the RNAi therapy market. The report discusses the key factors shaping and driving the RNAi therapy business, and provides insights into the competitive landscape and emerging strategies expected to significantly influence the market positions of companies currently involved in the development and commercialization of RNAi therapeutics.